Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2341070453;70454;70455 chr2:178575904;178575903;178575902chr2:179440631;179440630;179440629
N2AB2176965530;65531;65532 chr2:178575904;178575903;178575902chr2:179440631;179440630;179440629
N2A2084262749;62750;62751 chr2:178575904;178575903;178575902chr2:179440631;179440630;179440629
N2B1434543258;43259;43260 chr2:178575904;178575903;178575902chr2:179440631;179440630;179440629
Novex-11447043633;43634;43635 chr2:178575904;178575903;178575902chr2:179440631;179440630;179440629
Novex-21453743834;43835;43836 chr2:178575904;178575903;178575902chr2:179440631;179440630;179440629
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACC
  • RefSeq wild type template codon: TGG
  • Domain: Ig-129
  • Domain position: 66
  • Structural Position: 151
  • Q(SASA): 0.2921
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/N rs1473979874 -0.468 0.491 N 0.437 0.334 0.337868961071 gnomAD-2.1.1 4.02E-06 None None None None I None 0 0 None 0 0 None 0 None 0 8.88E-06 0
T/N rs1473979874 -0.468 0.491 N 0.437 0.334 0.337868961071 gnomAD-4.0.0 1.36855E-06 None None None None I None 0 0 None 0 0 None 0 0 1.79914E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.06 likely_benign 0.0803 benign -0.876 Destabilizing None N 0.149 neutral N 0.378828778 None None I
T/C 0.3904 ambiguous 0.4745 ambiguous -0.499 Destabilizing 0.901 D 0.521 neutral None None None None I
T/D 0.7739 likely_pathogenic 0.832 pathogenic 0.234 Stabilizing 0.561 D 0.501 neutral None None None None I
T/E 0.6877 likely_pathogenic 0.741 pathogenic 0.231 Stabilizing 0.561 D 0.521 neutral None None None None I
T/F 0.5684 likely_pathogenic 0.7215 pathogenic -1.038 Destabilizing 0.818 D 0.561 neutral None None None None I
T/G 0.1869 likely_benign 0.2358 benign -1.113 Destabilizing 0.209 N 0.387 neutral None None None None I
T/H 0.4995 ambiguous 0.5782 pathogenic -1.364 Destabilizing 0.965 D 0.519 neutral None None None None I
T/I 0.5759 likely_pathogenic 0.6875 pathogenic -0.338 Destabilizing 0.003 N 0.248 neutral D 0.53227011 None None I
T/K 0.5647 likely_pathogenic 0.6517 pathogenic -0.512 Destabilizing 0.561 D 0.52 neutral None None None None I
T/L 0.242 likely_benign 0.3371 benign -0.338 Destabilizing 0.083 N 0.341 neutral None None None None I
T/M 0.1341 likely_benign 0.1715 benign -0.054 Destabilizing 0.818 D 0.536 neutral None None None None I
T/N 0.2426 likely_benign 0.2973 benign -0.445 Destabilizing 0.491 N 0.437 neutral N 0.494135797 None None I
T/P 0.6856 likely_pathogenic 0.7785 pathogenic -0.486 Destabilizing 0.662 D 0.524 neutral D 0.53227011 None None I
T/Q 0.4419 ambiguous 0.5033 ambiguous -0.606 Destabilizing 0.901 D 0.561 neutral None None None None I
T/R 0.4405 ambiguous 0.549 ambiguous -0.333 Destabilizing 0.722 D 0.542 neutral None None None None I
T/S 0.0976 likely_benign 0.117 benign -0.817 Destabilizing 0.016 N 0.173 neutral N 0.383791881 None None I
T/V 0.3538 ambiguous 0.4556 ambiguous -0.486 Destabilizing 0.038 N 0.311 neutral None None None None I
T/W 0.8823 likely_pathogenic 0.931 pathogenic -0.931 Destabilizing 0.991 D 0.539 neutral None None None None I
T/Y 0.5608 ambiguous 0.6789 pathogenic -0.692 Destabilizing 0.901 D 0.531 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.